- First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditions
- Total Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024
- Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024
- Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024
- Total Company Adjusted EBITDA(1) was $46.4 million in the first quarter of 2025 as compared with $58.5 million in the first quarter of 2024, a decrease of 20.6%; Digital Health reportable segment Adjusted EBITDA(1) increased to $3.7 million in the first quarter of 2025 from $3.5 million in the first quarter of 2024
- Adjusting for unusual or one-time items in the quarter, Adjusted Diluted Loss Per Share(3) was $(0.35) for the first quarter of 2025; This compares with Adjusted Earnings Per Share(3) of $0.07 for the first quarter of 2024
- On April 15, 2025, RadNet announced that it signed a definitive agreement to acquire iCAD, Inc. (“iCAD”) to accelerate AI-powered early detection and diagnosis of breast cancer
- RadNet revises full-year 2025 guidance levels with increases to Revenue and Adjusted EBITDA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.